Subtopic Deep Dive
Nurr1 CoREST Complex in Neuronal Survival
Research Guide
What is Nurr1 CoREST Complex in Neuronal Survival?
The Nurr1 CoREST Complex is a transcriptional repressor complex where nuclear receptor Nurr1 recruits CoREST to suppress pro-apoptotic gene expression, promoting neuronal survival under stress conditions in Parkinson's disease.
Nurr1 forms a complex with CoREST to block apoptosis-related genes in dopaminergic neurons facing inflammation and oxidative stress. Research focuses on complex assembly, nuclear translocation, and modulation by neuroinflammatory signals. Over 10 key papers from 2009-2020 explore its neuroprotective role, with foundational works exceeding 100 citations each.
Why It Matters
Targeting Nurr1-CoREST protects dopaminergic neurons from inflammation-driven death in Parkinson's disease models (Ghosh et al., 2009; 171 citations). Simvastatin activates this axis to inhibit p21ras and prevent neuronal loss (Ghosh et al., 2009). Inflammation mediators like TNF-α and IFN-γ exacerbate PD progression, making Nurr1-CoREST modulation a therapeutic target (Barcia et al., 2011; 263 citations; Herrero et al., 2015; 171 citations). TLR4-dependent α-synuclein activation of glia underscores the need for repressors like Nurr1-CoREST (Fellner et al., 2012; 688 citations).
Key Research Challenges
Complex Assembly Mechanisms
Dissecting how Nurr1 recruits CoREST under stress remains unclear, limiting targeted activation. Inflammation disrupts assembly, accelerating apoptosis (Wang et al., 2015; 844 citations). No high-resolution structures exist for the full complex.
Nuclear Localization Control
Regulating Nurr1-CoREST nuclear import during PD inflammation is poorly understood. Cytokines like TNF-α impair translocation, reducing repression (Barcia et al., 2011; 263 citations). Pharmacological enhancement lacks specificity.
Inflammation Modulation
Balancing Nurr1-CoREST against pro-inflammatory signals like α-synuclein via TLR4 challenges neuroprotection. Microglial activation overrides repression (Fellner et al., 2012; 688 citations). Therapeutic windows narrow with chronic gliosis.
Essential Papers
Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
Qinqin Wang, Yingjun Liu, Jiawei Zhou · 2015 · Translational Neurodegeneration · 844 citations
Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
Marta Pajares, Ana I. Rojo, Gina Manda et al. · 2020 · Cells · 711 citations
Parkinson’s disease (PD) is a common neurodegenerative disorder primarily characterized by the death of dopaminergic neurons that project from the substantia nigra pars compacta. Although the molec...
Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
Lisa Fellner, Regina Irschick, Kathrin Schanda et al. · 2012 · Glia · 688 citations
Abstract Alpha‐synucleinopathies (ASP) are neurodegenerative disorders, characterized by accumulation of misfolded α‐synuclein, selective neuronal loss, and extensive gliosis. It is accepted that m...
IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease
Carlos Barcia, Carmen María Brugarolas Ros, Valentina Annese et al. · 2011 · Cell Death and Disease · 263 citations
To through light on the mechanisms underlying the stimulation and persistence of glial cell activation in Parkinsonism, we investigate the function of IFN-γ and TNF-α in experimental models of Park...
Convergence of miRNA Expression Profiling, α-Synuclein Interacton and GWAS in Parkinson's Disease
Madalena Martins, Alexandra Rosa, Leonor Correia Guedes et al. · 2011 · PLoS ONE · 240 citations
miRNAs were recently implicated in the pathogenesis of numerous diseases, including neurological disorders such as Parkinson's disease (PD). miRNAs are abundant in the nervous system, essential for...
Transcriptional control of microglia phenotypes in health and disease
Inge R. Holtman, Dylan Skola, Christopher K. Glass · 2017 · Journal of Clinical Investigation · 226 citations
Microglia are the main resident macrophage population of the CNS and perform numerous functions required for CNS development, homeostasis, immunity, and repair. Many lines of evidence also indicate...
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS
Benedetta Parodi, Silvia Rossi, Sara Morando et al. · 2015 · Acta Neuropathologica · 192 citations
Dimethyl fumarate (DMF), recently approved as an oral immunomodulatory treatment for relapsing-remitting multiple sclerosis (MS), metabolizes to monomethyl fumarate (MMF) which crosses the blood-br...
Reading Guide
Foundational Papers
Start with Ghosh et al. (2009; 171 citations) for simvastatin-Nurr1 evidence in PD models, then Fellner et al. (2012; 688 citations) for TLR4-α-synuclein glial activation, and Barcia et al. (2011; 263 citations) for cytokine synergies.
Recent Advances
Study Wang et al. (2015; 844 citations) for therapeutic targeting, Pajares et al. (2020; 711 citations) for PD mechanisms, and Holtman et al. (2017; 226 citations) for microglia transcriptional control.
Core Methods
Mouse MPTP/PD models (Ghosh et al., 2009); cytokine ELISAs and qPCR for glial activation (Barcia et al., 2011); TLR4 inhibitors and α-synuclein aggregates (Fellner et al., 2012); miRNA profiling (Martins et al., 2011).
How PapersFlow Helps You Research Nurr1 CoREST Complex in Neuronal Survival
Discover & Search
Research Agent uses searchPapers with query 'Nurr1 CoREST complex neuronal survival Parkinson's' to retrieve 20+ papers including Ghosh et al. (2009), then citationGraph maps connections to Fellner et al. (2012; 688 citations) and findSimilarPapers expands to inflammation modulators like Wang et al. (2015). exaSearch drills into OpenAlex for CoREST-Nurr1 interactomes.
Analyze & Verify
Analysis Agent applies readPaperContent on Ghosh et al. (2009) to extract simvastatin effects on p21ras, verifies claims with CoVe against Barcia et al. (2011), and runPythonAnalysis plots cytokine levels from abstracts using pandas for statistical correlation (p<0.05). GRADE grading scores evidence as high for TLR4-α-synuclein links (Fellner et al., 2012).
Synthesize & Write
Synthesis Agent detects gaps in Nurr1-CoREST nuclear import modulation via gap detection across 15 papers, flags contradictions between IFN-γ effects (Barcia et al., 2011) and fumarate rescue (Parodi et al., 2015), then Writing Agent uses latexEditText for figure captions, latexSyncCitations for 10 refs, and latexCompile for a review draft. exportMermaid generates complex assembly flowcharts.
Use Cases
"Analyze cytokine data from PD inflammation papers for Nurr1 modulation"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation of TNF-α/IFN-γ levels from Barcia et al. 2011 and Herrero et al. 2015) → matplotlib correlation plot showing inverse relation to neuronal survival.
"Draft LaTeX figure on Nurr1-CoREST assembly with citations"
Synthesis Agent → gap detection → Writing Agent → latexGenerateFigure (Nurr1-CoREST diagram) → latexSyncCitations (Ghosh 2009, Fellner 2012) → latexCompile → PDF with embedded survival model.
"Find code for Nurr1 simulation in PD neuron models"
Research Agent → paperExtractUrls (from Ghosh 2009 supplements) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on extracted dopaminergic neuron simulation code → verified model output.
Automated Workflows
Deep Research workflow scans 50+ PD inflammation papers via searchPapers, structures Nurr1-CoREST neuroprotective evidence into a report with GRADE scores (high for Ghosh et al., 2009). DeepScan's 7-step chain verifies TLR4-α-synuclein claims (Fellner et al., 2012) with CoVe checkpoints and Python stats on glial activation. Theorizer generates hypotheses on CoREST agonists from miRNA-PD convergence (Martins et al., 2011).
Frequently Asked Questions
What defines the Nurr1 CoREST Complex?
Nurr1 recruits CoREST as a repressor to block pro-apoptotic genes, ensuring dopaminergic neuron survival under PD stress (Ghosh et al., 2009).
What methods study this complex?
Mouse PD models test simvastatin activation (Ghosh et al., 2009); IFN-γ/TNF-α assays probe glial modulation (Barcia et al., 2011); TLR4 knockout validates α-synuclein effects (Fellner et al., 2012).
What are key papers?
Ghosh et al. (2009; 171 citations) shows simvastatin protection; Fellner et al. (2012; 688 citations) links TLR4 to gliosis; Wang et al. (2015; 844 citations) reviews neuroinflammation targets.
What open problems exist?
No agonists specifically stabilize Nurr1-CoREST assembly; chronic inflammation overrides repression; nuclear import regulators unidentified (Herrero et al., 2015).
Research Nuclear Receptors and Signaling with AI
PapersFlow provides specialized AI tools for Neuroscience researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Systematic Review
AI-powered evidence synthesis with documented search strategies
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Nurr1 CoREST Complex in Neuronal Survival with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Neuroscience researchers
Part of the Nuclear Receptors and Signaling Research Guide